论文部分内容阅读
以往文献中已经提出多种影响肺癌病人生存的因素,如局部或远处转移、上腔静脉综合症及胸水等,但很少论及肺炎对肺癌病人生存的影响。作者分析了1984年1月至1986年12月在华盛顿的霍华德大学医院治疗的121例肺癌病人的病历,论述肺炎的发生率及肺炎对肺癌病人生存的影响。121例病人中,Ⅲ期和Ⅳ期病人分别占39.8％和38.9％,85例合并肺炎,其中37例(44％)为单一感染灶,48例(55％)则为多发性感染灶。在肺癌合并肺炎病人的痰液中检出的最常见的致病菌为甲/丙链球菌。有肺部感染者的中位生存期为4.2个月,明显低
In the past literature, many factors that affect the survival of lung cancer patients have been proposed, such as local or distant metastasis, superior vena cava syndrome, and pleural effusion, but few studies have addressed the impact of pneumonia on the survival of lung cancer patients. The authors analyzed the medical records of 121 lung cancer patients treated at the Howard University Hospital in Washington, D.C., from January 1984 to December 1986, and discussed the incidence of pneumonia and the impact of pneumonia on the survival of lung cancer patients. Among the 121 patients, 39.8% and 38.9% of the patients in stage III and IV were associated with pneumonia. Among them, 37 patients (44%) had a single lesion, and 48 patients (55%) had multiple lesions. The most common pathogen detected in the sputum of lung cancer patients with pneumonia is A/S. The median survival of those with pulmonary infection was 4.2 months, which was significantly lower